Is pentoxifylline the drug of the decade?
- 30 April 1994
- journal article
- editorial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 30 (4), 639-642
- https://doi.org/10.1016/s0190-9622(09)80111-4
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Treatment of Vasculogenic Sexual Dysfunction with PentoxifyllineJournal of the American Geriatrics Society, 1993
- Pentoxifylline in Management of Proteinuria in Diabetic NephropathyNephron, 1993
- Pentoxifylline in the Treatment of Vascular Impotence— Case ReportsAngiology, 1991
- Lack of Effect of Clonidine and Pentoxifylline in Short-Term Therapy of Diabetic Peripheral NeuropathyDiabetes Care, 1990
- Comparative Efficacy of Ketanserin and Pentoxiphylline in Treatment of Raynaud's PhenomenonAngiology, 1989
- White blood cells as mediators of hyperviscosity-induced tissue damage in neutrophilic vascular reactions: Therapy with pentoxifyllineJournal of the American Academy of Dermatology, 1989
- Pentoxifylline Increases Extremity Blood Flow in Diabetic Atherosclerotic PatientsArchives of Surgery, 1989
- Altered blood rheology in the pathogenesis of diabetic and other neuropathiesMuscle & Nerve, 1988
- Ketanserin: A novel cardiovascular drugDrug Development Research, 1986
- Effects of Ketanserin, a 5-HT2-Receptor Antagonist, on the Blood Flow Response to Temperature Changes in the Diabetic FootThe Journal of Clinical Pharmacology, 1985